No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: Results from two Swedish population‐based rheumatoid arthritis cohorts
- 29 September 2009
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (10), 2861-2869
- https://doi.org/10.1002/art.24855
Abstract
Objective To investigate the relative importance of shared etiologies for rheumatoid arthritis (RA) and ischemic heart disease (IHD) in terms of the well‐known increased risk of IHD in patients with RA, by assessing the occurrence of IHD up until the time of the onset of the first symptoms of RA. Methods We assessed the prevalence of a history of IHD, myocardial infarction (MI), and angina pectoris before the onset of RA symptoms in 2 large population‐based case–control studies. Patients with newly diagnosed RA according to the criteria of the American College of Rheumatology were included as cases. We used data from the Swedish Early Arthritis Register study and the Swedish Epidemiologic Investigation of Rheumatoid Arthritis case–control study and from general population controls. Information on IHD, MI, and angina pectoris was obtained from the nationwide Hospital Discharge Register and from self reports. We calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) to compare the prevalence of a history of IHD/MI/angina pectoris among patients with RA with that among population controls. Results We could not detect any increased occurrence of IHD, MI, or angina pectoris before the onset of symptoms of RA, regardless of whether data on IHD were obtained from the Hospital Discharge Register or were self reported. As detected in the Hospital Discharge Register, the OR for IHD overall was 1.0 (95% CI 0.9–1.1), the OR for MI was 1.0 (95% CI 0.9–1.1), and the OR for angina pectoris was 1.0 (95% CI 0.9–1.2). Conclusion Shared risk factors or susceptibilities for RA and IHD are likely to contribute less than RA‐related factors to the increased occurrence of IHD in patients with manifest RA. Nonetheless, the existence of shared factors associated with longer latency until the occurrence of IHD cannot be excluded.This publication has 24 references indexed in Scilit:
- Cardiovascular disease – the silent killer in rheumatoid arthritisClinical Medicine, 2008
- Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritisArthritis & Rheumatism, 2008
- Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?Annals Of The Rheumatic Diseases, 2008
- HLA–DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritisArthritis Care & Research, 2007
- Genes, environment and immunity in the development of rheumatoid arthritisCurrent Opinion in Immunology, 2006
- Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosisArthritis & Rheumatism, 2005
- How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?Arthritis & Rheumatism, 2005
- MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarctionNature Genetics, 2005
- Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population‐based cohort studyArthritis & Rheumatism, 2005
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988